Sign In

Login

Password

Forgot Password ? Sign Up

Fluvoxamin (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Fluvoxamin" in German language version.

refsWebsite
Global rank German rank
10nih.gov
4th place
7th place
9doi.org
2nd place
3rd place
3medscape.com
719th place
1,553rd place
2aerzteblatt.de
3,043rd place
200th place
1cas.org
8,332nd place
1,213th place
1europa.eu
68th place
29th place
1chemspider.com
8,573rd place
1,211th place
1wikidata.org
43rd place
985th place
1sigmaaldrich.com
924th place
87th place
1fachinfo.de
low place
2,942nd place
1jamanetwork.com
2,650th place
1,472nd place

aerzteblatt.de

cas.org

commonchemistry.cas.org

chemspider.com

doi.org

  • MJ Owens, DL Knight, CB Nemeroff: Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. In: Biological Psychiatry. 50. Jahrgang, Nr. 5, 1. September 2001, S. 345–50, doi:10.1016/s0006-3223(01)01145-3, PMID 11543737.
  • J. Kornhuber, M. Muehlbacher, S. Trapp, S. Pechmann, A. Friedl, M. Reichel, C. Mühle, L. Terfloth, T. Groemer, G. Spitzer, K. Liedl, E. Gulbins, P. Tripal: Identification of Novel Functional Inhibitors of Acid Sphingomyelinase. In: PLoS ONE. 6. Jahrgang, Nr. 8, 2011, S. e23852, doi:10.1371/journal.pone.0023852, PMID 18504571.
  • Eric J. Lenze, Caline Mattar, Charles F. Zorumski et al.: Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 – A Randomized Clinical Trial. In: JAMA. 12. November 2020, doi:10.1001/jama.2020.22760 (Online-Veröffentlichung, JAMA-Network [abgerufen am 14. November 2020]).
  • Gilmar Reis, Eduardo Augusto dos Santos Moreira-Silva, Daniela Carla Medeiros Silva, Lehana Thabane, Aline Cruz Milagres: Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. In: The Lancet Global Health. Band 0, Nr. 0, 27. Oktober 2021, doi:10.1016/S2214-109X(21)00448-4, PMID 34717820, PMC 8550952 (freier Volltext).
  • D. A. Ciraulo, R. I. Shader: Pharmacotherapy of Depression. 2nd Auflage. Springer, 2011, ISBN 978-1-60327-435-7, S. 49, doi:10.1007/978-1-60327-435-7.
  • Baumann P.: Pharmacokinetic-pharmacodynamic relationship of the Selective serotonin reuptake inhibitors. In: Clinical Pharmacokinetics. 31. Jahrgang, Nr. 6, 1996, S. 444–469, doi:10.2165/00003088-199631060-00004, PMID 8968657.
  • C.L. DeVane: Translational pharmacokinetics: current issues with newer antidepressants. In: Depression and Anxiety. 8. Jahrgang, Suppl 1, 1998, S. 64–70, doi:10.1002/(SICI)1520-6394(1998)8:1+<64::AID-DA10>3.0.CO;2-S, PMID 9809216.
  • Brigitta Bondy, Illja Spellmann: Pharmacogenetics of Antipsychotics: Useful For the Clinician? In: Curr Opin Psychiatry. 20. Jahrgang, Nr. 1. Lippincott Williams & Wilkins, Medscape 2007, S. 126–130, doi:10.1097/YCO.0b013e328017f69f, PMID 17278909 (medscape.com [abgerufen am 1. Februar 2008]).
  • Lisa A. Kroom: Drug Interactions With Smoking. In: Am J Health Syst Pharm. 64. Jahrgang, Nr. 18. American Society of Health-System Pharmacists, Medscape 10. Januar 2007, S. 1917–1921, doi:10.2146/ajhp060414, PMID 17823102 (medscape.com [abgerufen am 31. Januar 2008]).

europa.eu

echa.europa.eu

fachinfo.de

jamanetwork.com

  • Eric J. Lenze, Caline Mattar, Charles F. Zorumski et al.: Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 – A Randomized Clinical Trial. In: JAMA. 12. November 2020, doi:10.1001/jama.2020.22760 (Online-Veröffentlichung, JAMA-Network [abgerufen am 14. November 2020]).

medscape.com

nih.gov

ncbi.nlm.nih.gov

  • MJ Owens, DL Knight, CB Nemeroff: Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. In: Biological Psychiatry. 50. Jahrgang, Nr. 5, 1. September 2001, S. 345–50, doi:10.1016/s0006-3223(01)01145-3, PMID 11543737.
  • J. Kornhuber, M. Muehlbacher, S. Trapp, S. Pechmann, A. Friedl, M. Reichel, C. Mühle, L. Terfloth, T. Groemer, G. Spitzer, K. Liedl, E. Gulbins, P. Tripal: Identification of Novel Functional Inhibitors of Acid Sphingomyelinase. In: PLoS ONE. 6. Jahrgang, Nr. 8, 2011, S. e23852, doi:10.1371/journal.pone.0023852, PMID 18504571.
  • Gilmar Reis, Eduardo Augusto dos Santos Moreira-Silva, Daniela Carla Medeiros Silva, Lehana Thabane, Aline Cruz Milagres: Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. In: The Lancet Global Health. Band 0, Nr. 0, 27. Oktober 2021, doi:10.1016/S2214-109X(21)00448-4, PMID 34717820, PMC 8550952 (freier Volltext).
  • A. M. Nia, K. M. Dahlem, N. Gassanov, H. Hungerbühler, U. Fuhr, F. Er: Clinical impact of fluvoxamine-mediated long QTU syndrome. In: European Journal of Clinical Pharmacology, 2012, 68, S. 109–111, PMID 21713517
  • Baumann P.: Pharmacokinetic-pharmacodynamic relationship of the Selective serotonin reuptake inhibitors. In: Clinical Pharmacokinetics. 31. Jahrgang, Nr. 6, 1996, S. 444–469, doi:10.2165/00003088-199631060-00004, PMID 8968657.
  • C.L. DeVane, H.S. Gill: Clinical Pharmacokinetics of Fluvoxamine: applications to dosage regime design. In: Journal of Clinical Psychiatry. 58. Jahrgang, Suppl 5, 1997, S. 7–14, PMID 9184622.
  • C.L. DeVane: Translational pharmacokinetics: current issues with newer antidepressants. In: Depression and Anxiety. 8. Jahrgang, Suppl 1, 1998, S. 64–70, doi:10.1002/(SICI)1520-6394(1998)8:1+<64::AID-DA10>3.0.CO;2-S, PMID 9809216.
  • Brigitta Bondy, Illja Spellmann: Pharmacogenetics of Antipsychotics: Useful For the Clinician? In: Curr Opin Psychiatry. 20. Jahrgang, Nr. 1. Lippincott Williams & Wilkins, Medscape 2007, S. 126–130, doi:10.1097/YCO.0b013e328017f69f, PMID 17278909 (medscape.com [abgerufen am 1. Februar 2008]).
  • Lisa A. Kroom: Drug Interactions With Smoking. In: Am J Health Syst Pharm. 64. Jahrgang, Nr. 18. American Society of Health-System Pharmacists, Medscape 10. Januar 2007, S. 1917–1921, doi:10.2146/ajhp060414, PMID 17823102 (medscape.com [abgerufen am 31. Januar 2008]).

pubchem.ncbi.nlm.nih.gov

sigmaaldrich.com

wikidata.org